Shares of Cooper Cos. climbed 3% to $55.27 in after-hours trading Thursday following reports that activist investor Jana Partners is demanding a leadership overhaul. The firm is pressuring the contact-lens manufacturer to replace its chief executive and explore a potential sale of its core business to reverse persistent underperformance.
A cloud of uncertainty is hanging over the communications sector as investors retreat from consumer-facing giants, unnerved by shifting market sentiment and impending regulatory hurdles. Shares in Comcast and Netflix faced sharp sell-offs today, signaling a broader loss of confidence in the stability of high-growth media and internet providers.
A retreat in Treasury yields provided a reprieve for the utilities sector, lifting shares of power producers after a prolonged period of downward pressure. The sector, which had struggled throughout the year during a sharp spike in bond yields, is showing signs of stabilizing as market interest rates pull back.
A 26% plunge for Xenon Pharmaceuticals highlights the volatility of clinical development, as the company halts enrollment for its depression drug azetukalner. While investors retreated from the biotech firm, the market rewarded Ultragenyx Pharmaceutical for a rare disease milestone and signaled confidence in the capital allocation strategy of BRT Apartments.
Ingredion shareholders are set for a modest payout boost, as the board confirmed a quarterly cash dividend increase to 83 cents per share. This adjustment from the previous 82-cent rate continues a long-standing pattern of third-quarter hikes for the food ingredient manufacturer, marking twelve consecutive years of growth.
Michael Murray has stepped into the dual role of chief executive and chief financial officer at Sadot Group, replacing Chagay Ravid. The transition, confirmed in a Thursday filing with the Securities and Exchange Commission, marks a significant shift in the company’s leadership structure as it navigates its next phase of operations.
With crude futures settling at $101.91 a barrel, U.S. equities clawed back recent losses as investors bet on the Federal Reserve’s strategy to tame inflation. The market shift followed signs of cooling energy costs and a cooling in Treasury yields, providing a reprieve from the volatility that defined the previous week.
The board of directors at BRT Apartments Corp. has greenlit a fresh $10 million allocation for the company's share-repurchase program. This move effectively replenishes the real estate investment trust's capital reserve earmarked for buying back its own stock as it navigates the current market cycle.
Shares of Xenon Pharmaceuticals plunged 20% to $45.98 in after-hours trading Thursday after the company halted new enrollment for trials testing azetukalner. The decision follows a series of adverse events in studies targeting depression and bipolar disorder, prompting an immediate review by the firm's data safety monitoring board.
Phoenix Education Partners has reached an agreement to acquire Fuel50, an artificial intelligence platform specialized in workforce transformation. The acquisition aligns with the parent company of the University of Phoenix’s broader mission to integrate skills-focused educational tools for working professionals and corporate partners navigating shifting labor market demands.
Oil futures retreated to $101.91 a barrel, easing investor anxiety over energy-driven inflation and sparking a broad rally across U.S. markets. With crude prices contained and confidence in Federal Reserve Chairman Kevin Warsh’s policy strategy growing, major indices clawed back recent losses during Thursday’s trading session.
The Food and Drug Administration has cleared Fayuvi as the first treatment for Sanfilippo syndrome type A, a rare genetic disorder that progressively damages the brain and nervous system. This landmark decision marks a shift from merely managing symptoms to addressing the underlying course of the debilitating inherited disease.
Nearly two decades after its exit, ExxonMobil is closing in on a preliminary deal to resume oil field investments in Venezuela. The move arrives as energy markets struggle to price in the escalating conflict in Iran, with major investors seeking stability in South American reserves to hedge against geopolitical uncertainty.
The Food and Drug Administration has granted approval to Fayuvi, the first treatment specifically designed to address the underlying progression of Sanfilippo syndrome type A. Following the announcement, shares of Ultragenyx Pharmaceutical rose 13% to close at $14.50, signaling a potential recovery for the company after a volatile year.
A retreat in oil prices and Treasury yields has reignited investor appetite for raw materials, pushing metal and grain producers higher across the board. The cooling of broader economic pressures provided the necessary relief to alleviate long-standing demand concerns that previously weighed on the sector's performance throughout the trading session.
Fifty years of uninterrupted payout increases have earned McDonald’s a rare seat among the elite "Dividend Kings." The fast-food giant announced a 3.8% bump to its quarterly dividend this week, signaling a long-term commitment to shareholder returns that has persisted through five decades of shifting consumer habits and market volatility.
Industrial and transportation stocks held steady today as manufacturing output concerns weighed on investor sentiment. Boeing shares deepened their slide following critical updates regarding 737 MAX production rates, while broader industrial performance remained muted against a backdrop of shifting labor demands and strategic pivots across the global automotive and defense landscape.
A surge in drug development optimism propelled health care stocks higher, led by a pivotal FDA approval for Ultragenyx. The rare disease specialist saw its shares rally after regulators cleared its gene therapy for a pediatric neurodevelopmental disorder, signaling a significant breakthrough for the company’s specialized treatment pipeline.
Consumer sector equities climbed on Tuesday as Federal Reserve interest rate policy began to soothe investor anxiety regarding runaway inflation. The broader market sentiment shifted toward stability, allowing retail and lifestyle brands to recover ground lost during recent sessions of economic volatility across domestic markets.
Modine shareholders will see the formal separation of its performance technologies unit on September 28, triggering a complex merger with Gentherm that involves the issuance of 2.9 million new shares and a recalibrated dividend structure to preserve the tax-free status of the transaction.
Financial sector shares traded sideways on Tuesday as investors recalibrated their portfolios following a decline in Treasury yields. The move reflects a broader market sensitivity to interest rate fluctuations, which directly impact the lending margins that underpin bank profitability in the current economic climate.
Disney is accelerating its streaming pivot with a structural shakeup, elevating Adam Smith to lead its global direct-to-consumer business while tasking Joe Earley with a newly minted role focused on television franchise strategy. These shifts consolidate oversight for platforms like Disney+ and Hulu under a streamlined executive hierarchy.
A single lot of 0.9% sodium chloride injection is under voluntary recall after reports revealed a dangerous packaging error. The 100-milliliter units, intended for clinical use, may contain potassium chloride instead of the labeled saline solution, posing a significant health risk to patients receiving the misidentified intravenous fluids.
A sharp pivot in market sentiment pushed technology shares higher, as investors renewed their focus on the artificial intelligence sector. Bolstered by a cooling in Treasury yields and stabilizing oil prices, the rally signaled a fresh appetite for risk across the broader equity market.
Forty-one state attorneys general have secured a $75.5 million settlement from Credit Acceptance Corporation, concluding a year-long legal battle over allegations of predatory auto lending. The agreement resolves claims that the company targeted low-income consumers with deceptive loan terms and exorbitant interest rates, though the firm admits no wrongdoing.
Lisata Therapeutics shares surged 17% to $1.72 on Tuesday following the announcement of its acquisition of Marea Therapeutics. While the move signals a strategic shift for the biotech firm, the company’s stock remains down 12% for the year as investors weigh the long-term potential of the newly acquired drug candidates.
Shareholders of Fifth Third Bancorp are set to receive a larger slice of the bank's earnings following a 5% hike in the quarterly dividend. The move lifts the per-share distribution to 42 cents, signaling a renewed commitment to returning capital to investors as the fiscal year enters its final quarter.
Nearly 77% of shareholders have chosen to receive their 2025-26 dividends in stock rather than cash, signaling strong investor confidence in the French spirits group. This decision results in the issuance of over 256,000 new shares, effectively reducing the company’s immediate cash outflow to 29.2 million euros.
Shares of Hallador Energy climbed 8% to $15.90 on Thursday after the company finalized a $600 million senior secured term loan. The capital injection provides a critical financial foundation for the firm’s 460-megawatt Turtle Creek gas-fired power project, which has faced recent delays in its development timeline.
Crude futures retreated on Thursday as the immediate threat of Middle Eastern supply disruptions eased. Saudi Arabia successfully rerouted crude loadings away from the idle Yanbu port, while the resumption of regional flows helped dampen the recent market volatility that had previously pushed prices to higher levels.
